Sandoz México

Sandoz México company information, Employees & Contact Information

Explore related pages

Related company profiles:

Somos líder mundial en medicamentos genéricos y biocomparables. Estamos presentes en más de 100 países y nuestros medicamentos atienden a unos 500 millones de personas cada año. Consulta nuestro aviso de privacidad en: https://www.sandoz.com.mx/aviso-de-privacidad.html

Company Details

Employees
159
Address
Ciudad De México, México, Mx
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
ciudad de méxico, México
Looking for a particular Sandoz México employee's phone or email?

Sandoz México Questions

News

Product Safety Notices - Sandoz

Product Safety Notices Sandoz

Sandoz launches renewable energy partnership to cover nearly 90% of electricity demand for European operations - Sandoz

Sandoz launches renewable energy partnership to cover nearly 90% of electricity demand for European operations Sandoz

Unseen Costs of MS - Sandoz

Unseen Costs of MS Sandoz

Strengthening Europe’s antibiotic independence: Sandoz adopts Alpbach Communiqué to safeguard EU-based antibiotic production - Sandoz

Strengthening Europe’s antibiotic independence: Sandoz adopts Alpbach Communiqué to safeguard EU-based antibiotic production Sandoz

Sandoz further asserts leadership in biosimilars, breaking ground on new Slovenia facility to expand European biosimilar hub and global market reach - Sandoz

Sandoz further asserts leadership in biosimilars, breaking ground on new Slovenia facility to expand European biosimilar hub and global market reach Sandoz

Sandoz enters global collaboration license agreement with Henlius to commercialize leading oncology therapy, ipilimumab, in multiple indications - Sandoz

Sandoz enters global collaboration license agreement with Henlius to commercialize leading oncology therapy, ipilimumab, in multiple indications Sandoz

Sandoz launches Pyzchiva® autoinjector, first commercially available in Europe for ustekinumab biosimilars - Sandoz

Sandoz launches Pyzchiva® autoinjector, first commercially available in Europe for ustekinumab biosimilars Sandoz

Sandoz signs non-binding term sheet with Evotec SE to - GlobeNewswire

Sandoz signs non-binding term sheet with Evotec SE to GlobeNewswire

Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1] - Sandoz

Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1] Sandoz

Sandoz opens new Device Development Center in Cambridge, UK - Sandoz

Sandoz opens new Device Development Center in Cambridge, UK Sandoz

Business - Sandoz

Business Sandoz

News Archive - Sandoz

News Archive Sandoz

Generics - Sandoz

Generics Sandoz

Sandoz joins Energize Program to support suppliers in decarbonization efforts - Sandoz

Sandoz joins Energize Program to support suppliers in decarbonization efforts Sandoz

About Sandoz - Sandoz

About Sandoz Sandoz

Driving impact and access - Sandoz

Driving impact and access Sandoz

Sandoz Convenes Diverse Stakeholders to Discuss a Path Forward for Generic Drug Sustainability in the US - Sandoz

Sandoz Convenes Diverse Stakeholders to Discuss a Path Forward for Generic Drug Sustainability in the US Sandoz

Sandoz signs Science Based Targets Initiative (SBTi) Commitment Letter - Sandoz

Sandoz signs Science Based Targets Initiative (SBTi) Commitment Letter Sandoz

Environment - Sandoz

Environment Sandoz

Sandoz Issues Recall of One Lot of Enoxaparin - Sandoz

Sandoz Issues Recall of One Lot of Enoxaparin Sandoz

Information for Patients - Sandoz

Information for Patients Sandoz

Flexible-Hybrid Working at Sandoz - Sandoz

Flexible-Hybrid Working at Sandoz Sandoz

Novartis issues EGM Invitation and Shareholder Information Brochure. Sandoz publishes Listing Prospectus ahead of proposed Spin-off vote - Novartis

Novartis issues EGM Invitation and Shareholder Information Brochure. Sandoz publishes Listing Prospectus ahead of proposed Spin-off vote Novartis

Sandoz receives US FDA approval for biosimilar Hyrimoz® (adalimumab-adaz) high-concentration formulation - Novartis

Sandoz receives US FDA approval for biosimilar Hyrimoz® (adalimumab-adaz) high-concentration formulation Novartis

Amid Novartis spinoff efforts, Sandoz pledges $400M for biosimilar manufacturing in Slovenia - Fierce Pharma

Amid Novartis spinoff efforts, Sandoz pledges $400M for biosimilar manufacturing in Slovenia Fierce Pharma

Sandoz appoints new Board representative to global AMR Industry Alliance - Novartis

Sandoz appoints new Board representative to global AMR Industry Alliance Novartis

Sandoz looks to crowdsource digital health ideas with second hackathon at SXSW - Fierce Pharma

Sandoz looks to crowdsource digital health ideas with second hackathon at SXSW Fierce Pharma

Top Sandoz México Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant